Regarding CCL20, similar to our findings in NPC, its high expression has been confirmed to be associated with poorer prognosis in various cancers, including hepatocellular carcinoma (HCC)34, breast cancer35, colorectal cancer (CRC)36, and pancreatic cancer37. Here, CCL20 is linked to nasopharyngeal carcinoma.